Use of Intranasal Naloxone by Basic Life Support Providers
Sign Up to like & getrecommendations! Published in 2017 at "Prehospital Emergency Care"
DOI: 10.1080/10903127.2017.1282562
Abstract: Abstract Study Objectives: Intranasal delivery of naloxone to reverse the effects of opioid overdose by Advanced Life Support (ALS) providers has been studied in several prehospital settings. In 2006, in response to the increase in… read more here.
Keywords: intranasal naloxone; life support; naloxone basic; naloxone ... See more keywords
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Addiction Medicine"
DOI: 10.1097/adm.0000000000001073
Abstract: Buprenorphine-naloxone (BUP-NX) is a lifesaving treatment for opioid use disorder. The increasing use of illicitly manufactured fentanyl, however, has made initiating BUP-NX more likely to precipitate withdrawal—an experience that deters treatment and causes return to… read more here.
Keywords: intranasal naloxone; buprenorphine; bup; use ... See more keywords
Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real world.
Sign Up to like & getrecommendations! Published in 2018 at "Addiction"
DOI: 10.1111/add.14087
Abstract: The work by McDonald and colleagues [1] is a welcome addition to what is known about naloxone bioavailability and pharmacokinetics, combined with the promise of a fit-for-purpose naloxone product for lay-person administration. Intranasal and other… read more here.
Keywords: supply; real world; intranasal naloxone; withdrawal symptoms ... See more keywords
Treating gambling disorder with as needed administration of intranasal naloxone: a pilot study to evaluate acceptability, feasibility and outcomes
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Open"
DOI: 10.1136/bmjopen-2018-023728
Abstract: Background and aim There is growing interest in the use of medication-assisted treatments for gambling disorder (GD). Opioid receptor antagonists are hypothesised to blunt the craving associated with gambling. This study was designed to assess… read more here.
Keywords: gambling disorder; study; intranasal naloxone; feasibility ... See more keywords
1767-P: Intranasal Naloxone Prevents the Development of Hypoglycemia-Associated Autonomic Failure (HAAF) in Susceptible Individuals
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.2337/db20-1767-p
Abstract: Repeated hypoglycemic episodes can cause HAAF, i.e., blunted counter-regulatory hormone responses. We have shown that activating opiate receptors can induce HAAF in healthy participants subjected to subsequent experimentally induced hypoglycemia. However, we have noted inter-individual… read more here.
Keywords: hypoglycemia; haaf susceptible; intranasal naloxone; haaf ... See more keywords